Senior insider sale
TAYSHA GENE THERAPIES, INC. — senior position signals high conviction
$2.13M
400K shares
What this filing means
NAGENDRAN SUKUMAR plans to sell 400K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $2.13M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/10/2026ACC: 0001974158-26-000076
Director
Since Sep 2020
400K
Shares to sell
$2.13M
Approx. market value
200K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Stock Option Grant
N/A
1/2/2025
67.94KStock Option Grant
N/A
1/2/2024
132.06KTotal acquired200K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2025 | Stock Option Grant N/A | 67.94K | — |
1/2/2024 | Stock Option Grant N/A | 132.06K | — |
| Total | 200K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
200K
Market value
$831.3K
4/10/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
200K
Market value
$1.30M
7/10/2026
Total
Units
400K
Value
$2.13M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/10/2026 | 200K | $831.3K | — | Completed |
| Planned — Approximate Date | ||||
7/10/2026 | 200K | $1.30M | Nasdaq | Planned |
| Total | 400K | $2.13M | ||